Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian popu...

por Sagara, Hironori, Barbier, Nathalie, Ishii, Tsuyoshi, Yoshisue, Hajime, Nikolaev, Ivan, Hosoe, Motoi, Gon, Yasuhiro
Publicado 2021

A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combinat...

por Brittain, Dominic, D’Andrea, Peter, Gruen, Emilie, Hosoe, Motoi, Jain, Devendra, Jauernig, Juergen, Pethe, Abhijit, Scosyrev, Emil, Tanase, Ana-Maria, Tillmann, Hanns-Christian
Publicado 2022

One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PAL...

por Chapman, Kenneth, van Zyl-Smit, Richard, Maspero, Jorge, Kerstjens, Huib A M, Gon, Yasuhiro, Hosoe, Motoi, Tanase, Ana-Maria, Pethe, Abhijit, Shu, Xu, D’Andrea, Peter
Publicado 2021

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Pati...

por van Zyl-Smit, Richard N, Chapman, Kenneth R, Kerstjens, Huib A M, Gessner, Christian, Sagara, Hironori, Tanase, Ana-Maria, Hosoe, Motoi, Pethe, Abhijit, Lawrence, David, Tillmann, Hanns-Christian, D’Andrea, Peter
Publicado 2023